Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2019 2
2020 2
2021 10
2022 3
2023 5
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
A single-cell type transcriptomics map of human tissues.
Karlsson M, Zhang C, Méar L, Zhong W, Digre A, Katona B, Sjöstedt E, Butler L, Odeberg J, Dusart P, Edfors F, Oksvold P, von Feilitzen K, Zwahlen M, Arif M, Altay O, Li X, Ozcan M, Mardinoglu A, Fagerberg L, Mulder J, Luo Y, Ponten F, Uhlén M, Lindskog C. Karlsson M, et al. Among authors: altay o. Sci Adv. 2021 Jul 28;7(31):eabh2169. doi: 10.1126/sciadv.abh2169. Print 2021 Jul. Sci Adv. 2021. PMID: 34321199 Free PMC article.
Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial.
Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Lam S, Velioglu HA, Yang H, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Bayram C, Bolat I, Oner S, Tozlu OO, Arslan ME, Hacimuftuoglu A, Yildirim S, Arif M, Shoaie S, Zhang C, Nielsen J, Turkez H, Borén J, Uhlén M, Mardinoglu A. Yulug B, et al. Among authors: altay o. Transl Neurodegener. 2023 Jan 26;12(1):4. doi: 10.1186/s40035-023-00336-2. Transl Neurodegener. 2023. PMID: 36703196 Free PMC article. Clinical Trial.
Targeting PKLR in liver diseases.
Yuan M, Shi M, Yang H, Ashraf S, Iqbal S, Turkez H, Boren J, Zhang C, Uhlén M, Altay O, Mardinoglu A. Yuan M, et al. Among authors: altay o. Trends Endocrinol Metab. 2025 Apr 11:S1043-2760(25)00054-2. doi: 10.1016/j.tem.2025.03.009. Online ahead of print. Trends Endocrinol Metab. 2025. PMID: 40221236 Review.
Systems biology based drug repositioning for development of cancer therapy.
Turanli B, Altay O, Borén J, Turkez H, Nielsen J, Uhlen M, Arga KY, Mardinoglu A. Turanli B, et al. Among authors: altay o. Semin Cancer Biol. 2021 Jan;68:47-58. doi: 10.1016/j.semcancer.2019.09.020. Epub 2019 Sep 27. Semin Cancer Biol. 2021. PMID: 31568815 Review.
Addressing the heterogeneity in liver diseases using biological networks.
Lam S, Doran S, Yuksel HH, Altay O, Turkez H, Nielsen J, Boren J, Uhlen M, Mardinoglu A. Lam S, et al. Among authors: altay o. Brief Bioinform. 2021 Mar 22;22(2):1751-1766. doi: 10.1093/bib/bbaa002. Brief Bioinform. 2021. PMID: 32201876 Free PMC article. Review.
28 results